Byrne Asset Management LLC Exelixis, Inc. Transaction History
Byrne Asset Management LLC
- $126 Million
- Q2 2025
A detailed history of Byrne Asset Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Byrne Asset Management LLC holds 710 shares of EXEL stock, worth $31,573. This represents 0.02% of its overall portfolio holdings.
Number of Shares
710
Previous 310
129.03%
Holding current value
$31,573
Previous $11,000
181.82%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
637Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.49 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.28 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$1 Billion4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$659 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$524 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14.3B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...